Skip to main content
VCbacked
Log inGet Started

Aurum Biosciences

Glasgow, United Kingdom

Aurum Biosciences has develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need.

$928K raised
Jan 2024
Venture - Series Unknown
BiotechnologyHealth CarePharmaceutical

Top Investors

Scottish EnterpriseTRICAPITALInnoScot HealthScottish Health InnovationsInfinion Biopharma

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aurum Biosciences

How much funding has Aurum Biosciences raised?
Aurum Biosciences has raised $928K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
Who are Aurum Biosciences's investors?
Aurum Biosciences's investors include Scottish Enterprise, TRICAPITAL, InnoScot Health, Scottish Health Innovations, Infinion Biopharma.
Where is Aurum Biosciences headquartered?
Aurum Biosciences is headquartered in Glasgow, United Kingdom.
What does Aurum Biosciences do?
Aurum Biosciences has develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need.
What stage is Aurum Biosciences at?
Aurum Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Aurum Biosciences — Funding & Investors." VCBacked, January 24, 2024, https://www.vcbacked.co/company/aurum-biosciences. Accessed July 1, 2026.
APA
VCBacked. (2024). Aurum Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/aurum-biosciences
Wikipedia (cite web)
{{cite web |title=Aurum Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/aurum-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver
Rapport Therapeutics
Boston
Neuroglee Therapeutics
Singapore
Living In Silico Inc.
Brampton
Navrogen
Philadelphia
MY01
Montréal